Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:382463.
doi: 10.1155/2015/382463. Epub 2015 Sep 2.

Activated Complement Factors as Disease Markers for Sepsis

Jean Charchaflieh  1 , Julie Rushbrook  2 , Samrat Worah  2 , Ming Zhang  3
Affiliations
Review

Activated Complement Factors as Disease Markers for Sepsis

Jean Charchaflieh et al. Dis Markers. 2015.

Abstract

Sepsis is a leading cause of death in the United States and worldwide. Early recognition and effective management are essential for improved outcome. However, early recognition is impeded by lack of clinically utilized biomarkers. Complement factors play important roles in the mechanisms leading to sepsis and can potentially serve as early markers of sepsis and of sepsis severity and outcome. This review provides a synopsis of recent animal and clinical studies of the role of complement factors in sepsis development, together with their potential as disease markers. In addition, new results from our laboratory are presented regarding the involvement of the complement factor, mannose-binding lectin, in septic shock patients. Future clinical studies are needed to obtain the complete profiles of complement factors/their activated products during the course of sepsis development. We anticipate that the results of these studies will lead to a multipanel set of sepsis biomarkers which, along with currently used laboratory tests, will facilitate earlier diagnosis, timely treatment, and improved outcome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The pathways of activation of the complement system.
See this image and copyright information in PMC

References

    1. Marik P. E. Early management of severe sepsis: concepts and controversies. Chest. 2014;145(6):1407–1418. doi: 10.1378/chest.13-2104. - DOI - PubMed
    1. Cawcutt K. A., Peters S. G. Severe sepsis and septic shock: clinical overview and update on management. Mayo Clinic Proceedings. 2014;89(11):1572–1578. doi: 10.1016/j.mayocp.2014.07.009. - DOI - PubMed
    1. Leentjens J., Kox M., van der Hoeven J. G., Netea M. G., Pickkers P. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? The American Journal of Respiratory and Critical Care Medicine. 2013;187(12):1287–1293. doi: 10.1164/rccm.201301-0036cp. - DOI - PubMed
    1. Coelho F. R., Martins J. O. Diagnostic methods in sepsis: the need of speed. Revista da Associação Médica Brasileira. 2012;58(4):498–504. doi: 10.1590/s0104-42302012000400024. - DOI - PubMed
    1. Dellinger R. P., Levy M. M., Rhodes A., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Medicine. 2013;39(2):165–228. doi: 10.1007/s00134-012-2769-8. - DOI - PMC - PubMed

Publication types